Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The "START" (a Streamlined ART Initiation Strategy) Study

NCT01810289 is registered in ClinicalTrials.gov with University of California, San Francisco as lead sponsor.

Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01810289 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The "START" (a Streamlined ART Initiation Strategy) Study
Lead sponsor
University of California, San Francisco
Phase
Not applicable
Overall status
Completed
Start date
April 30, 2013
Completion date
August 31, 2016
Enrollment
12,024 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

hiv